Jean‐louis Laplanche

Jean‐louis Laplanche's AcademicInfluence.com Rankings

Psychology

#3399

World Rank

#3842

Historical Rank

Psychoanalysis

#57

World Rank

#97

Historical Rank

psychology Degrees

Download Badge

Psychology

Why Is Jean‐louis Laplanche Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jean‐louis Laplanche's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The language of psycho-analysis (1973) (934)
Signal transduction through prion protein. (2000) (795)
Quantifying prion disease penetrance using large population control cohorts (2016) (352)
Fantasy and the origins of sexuality. (1968) (331)
Essays on otherness (1999) (329)
Distinct molecular phenotypes in bovine prion diseases (2004) (325)
The language of psycho-analysis. (Trans. Donald Nicholson-Smith). (1973) (284)
Genetic susceptibility and transmission factors in scrapie: detailed analysis of an epidemic in a closed flock of Romanov (1999) (275)
Different allelic effects of the codons 136 and 171 of the prion protein gene in sheep with natural scrapie. (1995) (245)
New Foundations For Psychoanalysis (1989) (205)
Life and death in psychoanalysis (1976) (191)
PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. (1993) (190)
14-3-3 Protein, Neuron-Specific Enolase, and S-100 Protein in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease (1998) (170)
The theory of seduction and the problem of the other. (1997) (165)
Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders (2000) (155)
Formations of Fantasy (1987) (151)
The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease (1994) (150)
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial (2014) (141)
Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression (1998) (139)
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years (2012) (134)
Translation in astrocyte distal processes sets molecular heterogeneity at the gliovascular interface (2017) (107)
Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK (2003) (104)
Treacher Collins syndrome: a clinical and molecular study based on a large series of patients (2015) (102)
Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease (2016) (101)
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder (2002) (99)
Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt‐Jakob disease phenotype (2000) (98)
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study (2015) (95)
Deletions in the prion protein gene are not associated with CJD. (1993) (88)
Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. (1999) (87)
First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases (2000) (86)
The Human “Prion-like” Protein Doppel Is Expressed in Both Sertoli Cells and Spermatozoa* (2002) (83)
Molecular and functional MDR1‐Pgp and MRPs expression in human glioblastoma multiforme cell lines (2002) (83)
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic (2016) (83)
Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism (2005) (80)
A new point mutation in the prion protein gene at codon 210 in Creutzfeldt‐Jakob disease (1993) (78)
CSF detection of the 14-3-3 protein in unselected patients with dementia. (2002) (78)
Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline. (2015) (74)
Predictive Factors of Chronic Post-Surgical Pain at 6 Months Following Knee Replacement: Influence of Postoperative Pain Trajectory and Genetics. (2016) (74)
Paget's Disease of Bone in the French Population: Novel SQSTM1 Mutations, Functional Analysis, and Genotype–Phenotype Correlations (2006) (72)
Seduction, persecution, revelation. (1995) (69)
Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting (2013) (69)
Serotonin transporter gene and manic depressive illness: An association study (1997) (65)
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis (2014) (64)
Serotonin transporter gene polymorphism influences age at onset in patients with bipolar affective disorder (2002) (64)
Deletion in prion protein gene in a Moroccan family. (1990) (62)
Two novel insertions in the prion protein gene in patients with late-onset dementia. (1995) (61)
Variant Creutzfeldt–Jakob disease in France and the United Kingdom: Evidence for the same agent strain (2009) (59)
Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene (1996) (59)
The Language of Psychoanalysis (2018) (58)
Compassionate use of quinacrine in Creutzfeldt–Jakob disease fails to show significant effects (2004) (57)
Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. (2015) (55)
Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease (2012) (53)
Fantasme originaire, fantasmes des origines, origines du fantasme (1998) (53)
Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study. (2013) (53)
POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4 (2019) (52)
Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. (1999) (52)
Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease (2013) (52)
Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans (2004) (52)
Rapidly progressive Alzheimer's disease: a multicenter update. (2012) (51)
Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. (2002) (48)
The unconscious : A psychoanalytic study (1972) (48)
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. (2002) (47)
Novel approaches in diagnosis and therapy of Creutzfeldt–Jakob disease (2000) (47)
Lithium response in bipolar disorders and core clock genes expression (2018) (47)
Interpretation between determinism and hermeneutics: a restatement of the problem. (1992) (47)
Neuron Dysfunction Is Induced by Prion Protein with an Insertional Mutation via a Fyn Kinase and Reversed by Sirtuin Activation in Caenorhabditis elegans (2010) (47)
A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles (2014) (46)
V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation (2006) (46)
Apolipoprotein E gene polymorphism in early and late onset bipolar patients (1997) (43)
Gender, Sex, and the Sexual (2007) (42)
An Interview with Jean Laplanche (2001) (42)
Notes on Afterwardsness (2005) (41)
Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain (2018) (40)
Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg. (2013) (39)
Mechanisms of tramadol-related neurotoxicity in the rat: Does diazepam/tramadol combination play a worsening role in overdose? (2016) (39)
Age at onset in genetic prion disease and the design of preventive clinical trials (2019) (39)
14‐3‐3 Protein cerebrospinal fluid detection in human growth hormone–treated Creutzfeldt‐Jakob disease patients (2001) (39)
High genetic carrier frequency of Wilson’s disease in France: discrepancies with clinical prevalence (2018) (39)
Platelet Serotonergic Markers as Endophenotypes for Obsessive-Compulsive Disorder (2005) (38)
Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk (2012) (38)
Prion protein and neuronal differentiation: quantitative analysis of prnp gene expression in a murine inducible neuroectodermal progenitor. (1999) (36)
Glycoform-Selective Prion Formation in Sporadic and Familial Forms of Prion Disease (2013) (35)
The Unfinished Copernican Revolution (2005) (34)
Psychoanalysis as anti-hermeneutics (1996) (34)
Distribution of the M129V polymorphism of the prion protein gene in a Turkish population suggests a high risk for Creutzfeldt-Jakob disease (2001) (34)
Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory (2010) (34)
Epidemiogenetic study of French families with Paget's disease of bone. (2012) (33)
Clinical spectrum and outcomes in families with coronal synostosis and TCF12 mutations (2014) (33)
Primary Osteoporosis in Young Adults: Genetic Basis and Identification of Novel Variants in Causal Genes (2017) (33)
11 Scrapie, Chronic Wasting Disease, and Transmissible Mink Encephalopathy (2004) (31)
Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions. (2010) (31)
Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders. (2012) (30)
Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies. (1994) (29)
Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression. (2004) (29)
Genetics of Paget's disease of bone. (2006) (29)
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study (2020) (29)
Long-standing prion dementia manifesting as posterior cortical atrophy. (2012) (28)
Determination of 14–3–3 protein levels in cerebrospinal fluid from Creutzfeldt–Jakob patients by a highly sensitive capture assay (2001) (28)
14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis (2002) (28)
Freud and the sexual : essays 2000-2006 (2011) (28)
Apolipoprotein E in schizophrenia: A French association study and meta‐analysis (2003) (27)
Age of onset in genetic prion disease and the design of preventive clinical trials (2018) (27)
Creutzfeldt‐Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma (1997) (27)
Prion‐like protein Doppel expression is not modified in scrapie‐infected cells and in the brains of patients with Creutzfeldt–Jakob disease (2003) (26)
A Genome Wide Association Study Links Glutamate Receptor Pathway to Sporadic Creutzfeldt-Jakob Disease Risk (2015) (26)
Large deletions encompassing the TCOF1 and CAMK2A genes are responsible for Treacher Collins syndrome with intellectual disability (2013) (26)
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study (2020) (25)
Pilot Study Examining the Frequency of Several Gene Polymorphisms Involved in Morphine Pharmacodynamics and Pharmacokinetics in a Morbidly Obese Population (2011) (25)
Inherited prion disease. (1993) (25)
Transference: its Provocation by the Analyst (2014) (25)
Creutzfeldt-Jakob disease (1998) (23)
Spatio-Developmental Distribution of the Prion-Like Protein Doppel in Mammalian Testis: A Comparative Analysis Focusing on Its Presence in the Acrosome of Spermatids1 (2006) (22)
Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain (2016) (22)
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients. (2015) (22)
Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009 (2017) (22)
French autochthonous scrapied sheep without the 136Val PrP polymorphism (2004) (22)
THE SO‐CALLED‘DEATH DRIVE’: A SEXUAL DRIVE1 (2004) (21)
Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein. (2016) (20)
PrP immunohistochemistry: Different protocols, including a procedure for long formalin fixation, and a proposed schematic classification for deposits in sporadic Creutzfeldt‐Jakob disease (2000) (20)
Striking PrPsc heterogeneity in inherited prion diseases with the D178N mutation (2004) (20)
Creutzfeldt-Jakob disease with long duration and panencephalopathic lesions: Molecular analysis of one case (1998) (20)
Interview With Jean Laplanche. (2015) (20)
Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals (2020) (20)
Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease. (2004) (19)
Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat (2019) (19)
Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease (1999) (18)
Hölderlin et la question du père (1961) (18)
Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers. (2016) (18)
Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts. (2016) (17)
The Drive and its Source-Object: its Fate in the Transference (2005) (17)
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease (2019) (16)
KCNH2 polymorphism and methadone dosage interact to enhance QT duration. (2014) (16)
Correction: Glycoform-Selective Prion Formation in Sporadic and Familial Forms of Prion Disease (2013) (15)
Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice. (2019) (15)
Exacerbated CSF abnormalities in younger patients with Alzheimer's disease (2013) (15)
Biomarker profiles of Alzheimer’s disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau (2019) (15)
Diagnostic value of CSF 14‐3‐3 detection in sporadic CJD diagnosis according to the age of the patient (2006) (14)
Genotyping Test with Clinical Factors: Better Management of Acute Postoperative Pain? (2015) (14)
Jean Laplanche: Seduction, Translation and the Drives : A Dossier (1992) (14)
A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P‐glycoprotein (2000) (13)
Human prion diseases: from antibody screening to a standardized fast immunodiagnosis using automation (2008) (13)
Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992–7 (2000) (13)
10 Scrapie, Chronic Wasting Disease, and Transmissible Mink Encephalopathy (1999) (12)
Late neurological presentations of Wilson disease patients in French population and identification of 8 novel mutations in the ATP7B gene. (2007) (12)
Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt–Jakob disease (2008) (12)
Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know (2019) (12)
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview (2021) (12)
Loss of Cerebellar Granule Neurons Is Associated With Punctate but Not With Large Focal Deposits of Prion Protein in Creutzfeldt-Jakob Disease (2009) (11)
Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report. (2014) (11)
Rare E196K mutation in the PRNP gene of a patient exhibiting behavioral abnormalities (2010) (11)
Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines (2008) (11)
Hypogonadism in AIDS. (1988) (11)
HLA in French patients with variant Creutzfeldt-Jakob disease (2003) (11)
Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt–Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes (2011) (11)
Autosomal recessive Treacher Collins syndrome due to POLR1C mutations: Report of a new family and review of the literature (2019) (11)
[Prion protein: structure, functions and polymorphisms associated with human spongiform encephalopathies]. (1995) (11)
A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients. (2000) (10)
Determination of sets of covariating gene expression using graph analysis on pairwise expression ratios (2018) (10)
Serotonin and human immunodeficiency viruses. (1989) (10)
Masochism and the General Theory of Seduction (2005) (10)
Camurati–engelmann disease with obesity in a newly identified family carrying a missense p.Arg156Cys mutation in the TGFB1 gene (2013) (10)
Cluster of Creutzfeldt–Jakob disease in France associated with the codon 200 mutation (E200K) in the prion protein gene (1998) (10)
The screening of Alzheimer’s patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trials (2014) (9)
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview (2021) (9)
QT length during methadone maintenance treatment: gene × dose interaction (2019) (9)
Selecting reference genes in RT-qPCR based on equivalence tests: a network based approach (2019) (9)
Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders. (2018) (8)
New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease (2012) (8)
A case of Gerstmann–Sträussler–Scheinker disease with a novel six octapeptide repeat insertion (2011) (8)
Specificity of terminological problems in the translation of Freud (1991) (8)
Hölderlin and the question of the father (2007) (8)
OPRM1 polymorphism and lifetime suicide attempts among stabilized, methadone-maintained outpatients (2014) (8)
Variation at the ADAM10 gene locus is not associated with Creutzfeldt–Jakob disease (2003) (8)
[Fatal familial insomnia: phenotypic changes determined by polymorphism of the codon 129]. (1997) (8)
Involvement of PKR in Alzheimer's Disease (2014) (8)
Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study. (2020) (7)
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers. (2018) (7)
High frequency of a 30‐bp deletion of Epstein–Barr virus latent membrane protein 1 gene in primary HIV non‐Hodgkin's brain lymphomas (2002) (7)
Neurobehavioral effects of lithium in the rat: Investigation of the effect/concentration relationships and the contribution of the poisoning pattern (2017) (7)
[Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid]. (1999) (7)
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study (2015) (6)
Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships (2018) (6)
[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases]. (2017) (6)
To Situate Sublimation (1984) (6)
Translational study of the whole transcriptome in rats and genetic polymorphisms in humans identifies LRP1B and VPS13A as key genes involved in tolerance to cocaine-induced motor disturbances (2020) (5)
Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains (2017) (5)
Time and the Other (2005) (5)
A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease (2020) (5)
Proceedings of Réanimation 2017, the French Intensive Care Society International Congress (2017) (5)
[Novel psychoactive substances: a review]. (2015) (5)
Fluorine 18-labeled fluorodeoxyglucose positron emission tomography in familial Creutzfeldt-Jakob disease. (2008) (4)
Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease (2012) (4)
Acute Poisoning with Rhabdomyolysis in the Intensive Care Unit: Risk Factors for Acute Kidney Injury and Renal Replacement Therapy Requirement (2020) (4)
Exigency and Going Astray (2006) (4)
Lithium effects on serine-threonine kinases activity: High throughput kinomic profiling of lymphoblastoid cell lines from excellent-responders and non-responders bipolar patients (2018) (4)
Plasma tau, NfL, GFAP and UCHL1 as candidate biomarkers of alcohol withdrawal‐associated brain damage: A pilot study (2022) (4)
Ascorbic Acid Deficiency Prevalence and Associated Cognitive Impairment in Alcohol Detoxification Inpatients: A Pilot Study (2021) (4)
Interpreting (with) Freud (2006) (4)
Sexuality and Attachment in Metapsychology (2018) (4)
Should We Burn Melanie Klein? (2019) (4)
Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: A pilot study (2019) (3)
Serotonin transporter gene polymorphism and psychiatric disorders in NF1 patients. (2001) (3)
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging (2022) (3)
[Analysis of the PrP gene in a Tunisian family with Creutzfeldt-Jakob disease]. (1991) (3)
The neurobehavioral effects of the designer drug naphyrone – an experimental investigation with pharmacokinetics and concentration/effect relationship in mice (2020) (3)
Risk and Protective Factors of Lifetime Cocaine-Associated Chest Pain (2021) (3)
Apolipoprotein E in Creutzfeldt-Jakob disease (1995) (3)
A French cluster of Creutzfeldt–Jakob disease: a molecular analysis (2002) (3)
A metapsychology put to the test of anxiety. (1981) (2)
Three meanings of the word “unconscious” in the framework of the General Theory of Seduction (2018) (2)
[Usefulness of molecular genetic analysis of the PRNP gene in patients with cerebellar ataxia: a new case of fatal familial insomnia]. (2003) (2)
Occurrence and severity of cocaine-induced hallucinations: Two distinct phenotypes with shared clinical factors but specific genetic risk factors. (2022) (2)
The normal distribution of PRNP codon 129 polymorphism in the Moroccan population (Arabs and Casablanca residents). (2008) (2)
Genome-wide association study identifies risk variants for sporadic Creutzfeldt-Jakob disease in STX6 and GAL3ST1 (2020) (2)
[Bovine spongiform encephalopathy: a new entity caused by a non-conventional transmissible agent]. (1990) (2)
[Molecular basis of familial and sporadic forms of human prion diseases]. (1994) (2)
A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles (2014) (1)
[A study network of human spongiform encephalopathies: 1st results]. (1994) (1)
Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals (2020) (1)
CSF PKR Is a Diagnostic and Prognostic Marker in Alzheimer's Disease (IN3-1.005) (2013) (1)
Human CJD and Trace Elements (2002) (1)
CSF PKR can predict cognitive decline in Alzheimer’s disease (2013) (1)
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic (2015) (1)
[Transmissible animal spongiform encephalopathies]. (1994) (1)
International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease (2020) (1)
11 – Human CJD and Trace Elements: BRAIN STATUS OF SOME TRACE ELEMENTS IN PATIENTS WITH CREUTZFELDT-JAKOB: INFLUENCE OF BIOCHEMICAL AND GENETIC VARIABILITY OF HUMAN PRION STRAINS? (2002) (1)
[Incidence of Creutzfeldt-Jakob disease in France, 1992-1995]. (1997) (1)
[Interpretation between determinism and hermeneutics. A new approach]. (1992) (1)
Gerstmann-Straussler-Scheinker disease presenting as corticobasal degeneration. (2003) (1)
Forces at play in psychical conflict (2017) (1)
Kinematical probes of neutrino mass (1994) (1)
New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer’s disease (2012) (1)
The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19) (2022) (1)
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging (2022) (0)
Interview: Jean Laplanche: The other within - Rethinking psychoanalysis (2000) (0)
Distinctmolecularphenotypes inbovinepriondiseases (2013) (0)
Childhood Trauma and the Severity of past Suicide Attempts in Outpatients with Cocaine Use Disorders (2021) (0)
THE UNCONSCIOUS AS A MESSAGE FROM THE OTHER. THEORY AND PRACTICE OF PSYCHOANALYSIS ACCORDING TO JEAN LAPLANCHE (2018) (0)
The Psychoanalysis of Babies (2007) (0)
Principles ofsychic function. (1969) (0)
[Genetics of human subacute spongiform encephalopathies]. (1999) (0)
[A revolution forever occulted]. (1989) (0)
[Not Available]. (1947) (0)
Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD (2018) (0)
[Proteins, genes and early diagnosis of Alzheimer's disease]. (1990) (0)
LES MALADIES A PRIONS : UN DOUBLE DETERMINISME GENETIQUE ET INFECTIEUX (1996) (0)
[Not Available]. (1947) (0)
Telomere length and mitochondrial DNA copy number in bipolar disorder: a sibling study. (2022) (0)
Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships (2018) (0)
Isolation and differential transcriptome of vascular smooth muscle cells and mid-capillary pericytes from the rat brain (2018) (0)
Age Modifies the Association Between Apolipoprotein E Genotype and Alzheimer's Disease: A CSF Biomarker-Based Multicentric Case-Control Study (2019) (0)
[Not Available]. (1947) (0)
Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence (2022) (0)
How to obtain DNA from injection drug users? (2011) (0)
CSF biomarker cut-offs for the diagnosis of Alzheimer's disease in a memory clinical center (2011) (0)
[Unconventional transmissible agents and prion protein: is something still missing?]. (1997) (0)
Infantile Sexuality and Attachment: Sexualité Infantile Et Attachement (2018) (0)
Beyond interest and limits of CSF biomarkers in clinical practice: The PLM study (2013) (0)
Circulating IL‐6 but not neutrophil extracellular traps levels can predict anakinra effectiveness in patients with severe COVID‐19 (2022) (0)
IV. Contre-courant (2014) (0)
A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein Communicated by: Mark H. Paalman Online Citation: Human Mutation, Mutation and Polymorphism Report #115 (2000) Online http://journals.wiley.com/1059-7794/pdf/mutation/mpr115.pdf (2000) (0)
CADASIL-Like MRI Hyperintensities in a Case of Neuropathologically Confirmed Alzheimer’s Disease (2011) (0)
Closing and Opening of the Dream: Must Chapter 7 be Rewritten? (2007) (0)
[A signaling function for the prion protein]. (2001) (0)
388. From candidate symptoms and endophenotypes to candidate genes (2000) (0)
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease (2019) (0)
A case report of transient but clinically relevant interaction between methadone and duloxetine: a reply to McCance-Katz et al. (2010) (0)
The neurobehavioral effects of the designer drug naphyrone – an experimental investigation with pharmacokinetics and concentration/effect relationship in mice (2020) (0)
[Recent data on prion diseases]. (2000) (0)
CSF AMYLOID-β 42/40 RATIO IN CLINICAL SETTINGS: A MULTICENTRIC STUDY (2014) (0)
Variant Creutzfeldt-Jakob disease in France and the United Kingdom (2008) (0)
[Molecular genetics of familial and sporadic forms of human prion diseases]. (1995) (0)
Particles in a Human T Lymphocyte Model Membranec + and PrP + Release of CD 4 an External Constraint Preventing the Annexin V Delays Apoptosis While Exerting (1999) (0)
Gene-Gene interactions and pleiotropy in the brain nicotinic pathway associated with the heaviness and precocity of tobacco smoking among outpatients with multiple substance use disorders (2019) (0)
Long-term amnesia following electroconvulsive therapy (2011) (0)
Education level and CSF biomarkers in Alzheimer's disease: The cognitive reserve theory (2010) (0)
Discussion : Commencer sa vie d'adulte (2000) (0)
Clustering suicidal phenotypes and genetic associations with brain-derived neurotrophic factor in patients with substance use disorders (2021) (0)
Edinburgh Explorer Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias (2018) (0)
[Human transmissible dementia: prion diseases?]. (1992) (0)
Creutzfeldt-Jakob disease in French West Indies. (1999) (0)
Increasing age and CSF biomarker levels in Alzheimer's disease: The PLM study (2013) (0)
P-952 - Candidate Genes for Pharmacogenetic Management of Methadone Optimal Dose (2012) (0)
An in vivo Caenorhabditis elegans model for therapeutic research in human prion diseases. (2021) (0)
PROTEINS WHICH INTERACT WITH WILD-TYPE AND MUTANT N-TERMINAL DOMAINS OF HUMAN PrPC (1997) (0)
BRAIN AND CEREBROSPINAL FLUID C-JUN N TERMINAL KINASE 3 LEVELS IN ALZHEIMER'S DISEASE: LINKS TO COGNITIVE DECLINE (2014) (0)
Apolipoprotein E in Creutzfeldt-Jakob disease. French Research Group on Epidemiology of Human Spongiform Encephalopathies. (1995) (0)
[Biochemical mechanisms in the physiopathology of migraine]. (2000) (0)
Abstracts and Keywords (2005) (0)
Prions lacking glycosylated PrP at the first N-glycosylation site in both variably proteasesensitive prionopathy and a familial prion disease: OR-41: (2012) (0)
5-12-07 Correlation of clinico-pathological phenotype and codon 129 genotype in patients with sporadic Creutzfeld-Jakob disease (CJ) (1997) (0)
Soluble amyloid precursor protein in cerebrospinal fluid as a potential biomarker of Alzheimer's disease using a new sensitive test (2011) (0)
CSF AD BIOMARKERS IN MEMORY CLINIC PATIENTS: THE EP.L.M.FR STUDY (2014) (0)
T HE G OTHIC AND THE E THNIC O THER A N I NTERVIEW WITH E NRIQUE A JURIA I BARRA (2022) (0)

This paper list is powered by the following services:

Jean‐louis Laplanche's Academic­Influence.com Rankings

Why Is Jean‐louis Laplanche Influential?

Jean‐louis Laplanche's Published Works

Published Works

Jean‐louis Laplanche's AcademicInfluence.com Rankings